未登录 ELEGANT: Elacestrant vs Standard ET in Women and Men With Node-positive, ER+, HER2-Early Breast Cancer (eBC) With High Risk of Recurrence - A Global, Multicenter, Randomized, Open- label Phase 3 Study ELEGANT研究:Elacestrant与标准ET治疗在淋巴结阳性、ER阳性、HER2阴性早期乳腺癌(eBC)伴高风险复发女性和男性患者中的比较——一项全球、多中心、随机、开放标签III期研究 Bardia, A.; Kaklamani, V.; O'Shaughnessy, J.; Schmid, P.; Beck, J. T.; De Laurentiis, M.; Curigliano, G.; Rugo, H.; Barcenas, C. H.; Gradishar, W. J.; Ignatiadis, M.; Cameron, D. A.; Tonini, G.; Scartoni, S.; Crozier, J.; Nicacio, L. V.; Wasserman, T.; Tolaney, S. M. 分享 收藏
Elacestrant in combination with abemaciclib in patients (pts) with brain metastasis (mets) from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer: Preliminary data from ELECTRA, an open-label, multicenter, phase Ib/II study Elacestrant与abemaciclib联合治疗雌激素受体阳性(ER+)、人表皮生长因子受体2阴性(HER2-)乳腺癌脑转移(mets)患者的初步数据:来自ELECTRA研究(一项开放标签、多中心、 Ib/II期研究)的初步数据 Ciruelos, E. M.; Hamilton, E. P.; Kim, S-B.; Im, Y-H.; Solis, E. Segui; Saenz, J. A. Garcia; Di Sanzo, A.; Lizarbe, M. Dominguez; Wasserman, T.; Theall, K. P.; Ibrahim, N. K. 分享 收藏
Elacestrant combinations in patients (pts) with estrogen receptor-positive (ER+), HER2-negative (HER2-) locally advanced or metastatic breast cancer (mBC): Preliminary data from ELEVATE, a phase Ib/II, open-label, umbrella study Elacestrant联合疗法在雌激素受体阳性(ER+)、人表皮生长因子受体2阴性(HER2-)局部晚期或转移性乳腺癌(mBC)患者(pts)中的研究:来自ELEVATE试验(一项开放标签的Ib/II期伞式研究)的初步数据 Rugo, H. S.; O'Shaughnessy, J.; Cortes, J.; Bardia, A.; Hamilton, E. P.; Hurvitz, S. A.; Kaklamani, V.; Mchayleh, W.; Romero, P. Munoz; Vallespir, B. Piza; Wasserman, T.; Theall, K. P.; Tolaney, S. M. 分享 收藏
Pudendal Nerve and Internal Pudendal Artery Damage May Contribute to Radiation-Induced Erectile Dysfunction Nolan, Michael W.; Marolf, Angela J.; Ehrhart, E. J.; Rao, Sangeeta; Kraft, Susan L.; Engel, Stephanie; Yoshikawa, Hiroto; Golden, Anne E.; Wasserman, Todd H.; Larue, Susan M. 分享 收藏
分享 收藏
分享 收藏
CLINICALLY MEANINGFUL DIFFERENCES IN PATIENT-REPORTED OUTCOMES WITH AMIFOSTINE IN COMBINATION WITH CHEMORADIATION FOR LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER: AN ANALYSIS OF RTOG 9801 Sarna, Linda; Swann, Suzanne; Langer, Corey; Werner-Wasik, Maria; Nicolaou, Nicos; Komaki, Ritsuko; Machtay, Mitchell; Byhardt, Roger; Wasserman, Todd; Movsas, Benjamin 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Quality of life (QOL) supercedes the classic predictors of survival in locally advanced non-small cell lung cancer (NSCLC): An analysis of radiation therapy oncology group (RTOG) 9801 Nicolaou, N.; Moughan, J.; Sarna, L.; Larger, C.; Wemer-Wasik, M.; Komaki, R.; Machtay, M.; Wasserman, T.; Bruner, D.; Movsas, B. 分享 收藏
Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and-neck cancer: 2-year follow-up of a prospective, randomized, phase III trial Wasserman, TH; Brizel, DM; Henke, M; Monnier, A; Eschwege, F; Sauer, R; Strnad, V 分享 收藏
Assessment and management of cutaneous reactions with amifostine administration:: Findings of the Ethyol (amifostine) Cutaneous Treatment Advisory Panel (ECTAP) Boccia, R; Anné, PR; Bourhis, J; Brizel, D; Daly, C; Holloway, N; Hymes, S; Koukourakis, M; Kozloff, M; Turner, M; Wasserman, T 分享 收藏
分享 收藏
分享 收藏
Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases Cutuli, B; Borel, C; Dhermain, F; Magrini, SM; Wasserman, TH; Bogart, JA; Provencio, M; de Lafontan, B; de la Rochefordiere, A; Cellai, E; Graic, Y; Kerbrat, P; Alzieu, C; Teissier, E; Dilhuydy, JM; Mignotte, H; Velten, M 分享 收藏
分享 收藏
分享 收藏
分享 收藏
The benefit of treatment intensification is age and histology-dependent in patients with locally advanced nonsmall cell lung cancer (NSCLC): A quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies 局部晚期非小细胞肺癌 (NSCLC) 患者强化治疗的益处与年龄和组织学有关: 放射治疗肿瘤学组 (RTOG) 放化疗研究的质量调整生存分析 Movsas, B; Scott, C; Sause, W; Byhardt, R; Komaki, R; Cox, J; Johnson, D; Lawton, C; Dar, AR; Wasserman, T; Roach, M; Lee, JS; Andras, E 分享 收藏